How environmental cues regulate adult stem cell and cancer cell activity through surface receptors is poorly understood. Angiopoietin-like proteins (ANGPTLs), a family of seven secreted glycoproteins, are known to support the activity of haematopoietic stem cells (HSCs) in vitro and in vivo 1-10 . ANGPTLs also have important roles in lipid metabolism, angiogenesis and inflammation, but were considered 'orphan ligands' because no receptors were identified 3,11,12 . Here we show that the immune-inhibitory receptor human leukocyte immunoglobulin-like receptor B2 (LILRB2) and its mouse orthologue paired immunoglobulin-like receptor (PIRB) are receptors for several ANGPTLs. LILRB2 and PIRB are expressed on human and mouse HSCs, respectively, and the binding of ANGPTLs to these receptors supported ex vivo expansion of HSCs. In mouse transplantation acute myeloid leukaemia models, a deficiency in intracellular signalling of PIRB resulted in increased differentiation of leukaemia cells, revealing that PIRB supports leukaemia development. Our study indicates an unexpected functional significance of classical immune-inhibitory receptors in maintenance of stemness of normal adult stem cells and in support of cancer development.
Co-transfection of ANGPTL2 or ANGPTL5 with LILRB2 extracellular domain (ECD) fused to human IgG-Fc (LILRB2-Fc) into 293T cells followed by immunoprecipitation and western blot showed that both ANGPTL2 and ANGPTL5 interacted with the ECD of LILRB2, but not that of Tie-2 ( Fig. 1c and Supplementary Fig. 1c ). The direct interactions between ANGPTLs and LILRB2 were confirmed by in vitro coimmunoprecipitation, using purified ANGPTL2-Flag or GST-ANGPTL5 and LILRB2-Fc ( Supplementary Fig. 1d ) and by surface plasmon resonance (SPR; Supplementary Fig. 3) . A liquid-phase binding assay with 125 I-labelled GST-ANGPTL5 demonstrated that the interaction between ANGPTL5 and cell-surface LILRB2 was specific and saturable, with half maximal saturation of the interaction as 5.5 6 1.1 nM (Fig. 1d, e ). Although untagged ANGPTLs bind to LILRB2, the type or the position of tagging could affect the binding (Supplementary Table 2 ). Because several ANGPTLs support expansion of HSCs 4-10 , we sought to determine whether ANGPTLs bound to LILRB2 or LAIR1 on primary human cord blood cells. Flow cytometry analysis showed that ANGPTL 1, 2, 5 and 7 all bound to LILRB2 1 human cord blood cells, and that ANGPTL2 and GST-ANGPTL5 had higher affinities ( Fig. 2a , Supplementary Fig. 4 and Supplementary Table 1 ). The binding of ANGPTL1 and ANGPTL7 to LAIR1 1 human cord blood cells was relatively weak ( Supplementary Fig. 5 ), and we therefore focused on studying the binding of ANGPTL2 and ANGPTL5 to LILRB2 in subsequent experiments.
We determined whether LILRB2 was expressed on human HSCs. Flow cytometry and quantitative (q)RT-PCR analyses showed that LILRB2 was expressed on the surface of 40-95% of human cord blood CD34 1 CD38 -CD90 1 cells (95% in the experiment shown in Fig. 2b and Supplementary Fig. 6 ); this population is enriched for HSCs.
GST-ANGPTL5 treatment induced increased phosphorylation of calcium/calmodulin-dependent protein kinase (CAMK)-2 and -4 in human cord blood mononuclear cells ( Supplementary Fig. 7 ). It is of note that CAMK4 is required for maintenance of the potency of HSCs 15 . Suppression of LILRB2 expression with short hairpin RNAs effectively reduced ANGPTL binding ( Supplementary Fig. 8 ). Importantly, the silencing of LILRB2 resulted in decreased repopulation of human cord blood HSCs as measured by reconstitution analysis in non-obese diabetic/severe combined immunodeficient (NOD/ SCID) mice (1% repopulation from cultured knockdown cells compared to 15% repopulation from cultured normal cells in medium STFA5; Fig. 2c ). Together, these data indicate that ANGPTL5 supports expansion of human cord blood HSCs 1 in a process at least partially mediated by the surface receptor LILRB2.
PIRB is the mouse membrane orthologue of human LILRBs 16, 17 . ANGPTL2, ANGPTL3 and GST-ANGPTL5 bound to PIRB as determined by flow cytometry ( Fig. 3a and Supplementary Fig. 9 ) and coimmunoprecipitation ( Fig. 3b and Supplementary Fig. 10 ). As with human cord blood HSCs, mouse HSCs were also enriched for PIRB expression ( Fig. 3c and Supplementary Fig. 11 ).
To study the function of PIRB in mouse HSCs, we used PIRBdeficient (PIRBTM) mice 18 , in which four exons encoding the transmembrane domain and part of the intracellular domain were deleted. PIRBTM cells freshly isolated from 3-week-old mice had significantly decreased CAMK4 phosphorylation, and binding of ANGPTL to PIRB induced phosphorylation of PIRB, recruitment of SHP-1 and SHP-2 (also known as PTPN6 and PTPN11, respectively) and CAMK4 activation ( Supplementary Figs 12 and 13 ). These results suggest that certain ANGPTLs may be the ligands of PIRB that activate CAMK4 in vivo. c, Human cord blood CD34 1 cells infected with LILRB2 shRNA-encoding virus (KD) or control (Ctrl) scramble shRNA virus were transplanted into sublethally irradiated NOD/SCID mice before or after culture for 10 days. SCF1TPO1Flt3L (STF) or STF1ANGPTL5 (STFA5) was used in the culture. Shown is the human donor repopulation after 2 months (n 5 5-11). *P , 0.05. Error bars denote s.e.m.
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Because SHP-2 and CAMK4 are required for the repopulation of HSCs 15, 19 , and the chemical inhibition of CAMK2, a homologue of CAMK4, induces differentiation and suppresses proliferation of myeloid leukaemia cells 20 , we sought to determine whether PIRB was important for HSC activity. Although the adult PIRBTM mice have certain immune and neuronal defects, they are grossly normal in haematopoiesis 16, 18 . Interestingly, competitive repopulation showed that PIRBTM fetal liver HSCs had approximately 50% decreased repopulation activity ( Supplementary Fig. 14) . Moreover, although ANGPTL2 and ANGPTL5 had little effect on ex vivo expansion of adult PIRBTM HSCs, they supported ex vivo expansion of adult wildtype HSCs ( Fig. 3d and Supplementary Fig. 14) , as we previously demonstrated 2 . Collectively, our results indicate that ANGPTLs bind human LILRB2 and mouse PIRB to support HSC repopulation.
On the basis of our in silico analysis of a pool of 9,004 samples described previously 21 , the level of LILRB2 messenger RNA is at least fourfold higher in the human acute monoblastic and monocytic leukaemia cells (M5 subtype of acute myeloid leukaemia (AML)) than in other AML cells ( Supplementary Fig. 15 ). As human acute monoblastic and monocytic leukaemia cells are often associated with rearrangement of mixed-lineage leukaemia (MLL; a histone methyltransferase deemed a positive global regulator of gene transcription), we used a retroviral MLL-AF9 transplantation mouse model 22, 23 to further examine the role of PIRB in regulation of AML development. Wild-type or PIRBTM donor Lin 2 cells infected by retroviral MLL-AF9-internal ribosome entry site (IRES)-yellow fluorescent protein (YFP) were used to induce AML as previously described 22, 23 . We examined PIRB expression in YFP 1 Mac-1 1 Kit 1 cells that may be enriched for AML-initiating activity 22, 23 , and found that about 80% of YFP 1 Mac-1 1 Kit 1 cells were PIRB 1 (Fig. 4a ). We next investigated whether PIRB was required for the induction of AML by MLL-AF9. Mice transplanted with MLL-AF9-transduced wildtype cells developed AML and died within approximately 5 weeks, whereas those transplanted with MLL-AF9-transduced PIRBTM cells were resistant to the induction of MLL-AF9 and developed AML much more slowly ( Fig. 4b and Supplementary Fig. 16 ). The significantly delayed development of the PIRBTM leukaemia was correlated with about a 50% reduction in numbers of white blood cells in circulation and a much less severe infiltration of myeloid leukaemia cells into the liver and spleen ( Fig. 4c, d ). Consistently, PIRB deficiency caused an approximately 50% reduction of YFP 1 Mac-1 1 Kit 1 cells in both bone marrow and peripheral blood ( Fig. 4d ). There were more CD3 1 or B220 1 cells in mice that received MLL-AF9-transduced PIRBTM donor cells than in those given wild-type cells (Fig. 4d ). These results demonstrate that PIRB-mediated signalling is associated with faster AML development and greater numbers of YFP 1 Mac-1 1 Kit 1 AML cells in vivo.
We further assessed whether PIRB potentially regulates differentiation and self-renewal of AML cells. Colony-forming unit (c.f.u.) assays showed that extrinsic ANGPTL stimulation led to increased c.f.u. numbers in wild-type but not PIRBTM AML cells, again indicating that PIRB directly mediates the effects of ANGPTLs (Supplementary Fig. 16d ). In addition, wild-type AML cells formed mostly compact colonies, whereas PIRBTM cells tended to form more diffuse ones (Fig. 4e ). The formation of diffuse colonies indicates high differentiation potential 24 . The inhibition of differentiation of AML cells by PIRB is in accordance with previous reports that PIRB inhibits differentiation of myeloid-derived suppressive cells 25 and osteoclasts 26 , as well as our data showing that endogenous ANGPTLs inhibit differentiation and increase replating efficiency of haematopoietic progenitors ( Supplementary Fig. 17 ). Moreover, PIRBTM primary colony-forming units were unable to form secondary colonies upon replating ( Fig. 4f ), indicating that PIRB supports self renewal of AML c.f.u. cells.
Finally, we analysed the molecular signalling triggered by the binding of ANGPTLs to PIRB in AML cells. PIRBTM AML cells had decreased phosphorylation of phosphatase SHP-2 ( Supplementary  Fig. 13d ), which is known to be associated with LILRB receptors and is an oncogene that supports leukaemia development 13, 16, 18, 27 . ANGPTLs also stimulated SHP-2 phosphorylation ( Supplementary  Fig. 13d ). Similar to untransformed PIRBTM cells, PIRBTM AML cells had decreased CAMK4 activation (data not shown). Furthermore, wild-type Mac-1 1 Kit 1 cells had much greater expression of leukaemia initiation/maintenance genes 22, 23 , but markedly decreased expression of myeloid-differentiation genes as determined by DNA microarray analyses ( Fig. 4g ). qRT-PCR confirmed the increased expression of several HOXA genes, Meis1, Eya1, Myb and Mef2c in wild-type Mac-1 1 Kit 1 cells than their PIRBTM counterparts ( Supplementary Fig. 18 ); these genes are critical for initiation or maintenance of MLL-rearranged 
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AML (refs 22, 23) . Similar to the MLL-AF9 model, the deficiency of PIRB in the AML1-ETO9a leukaemia model led to decreased numbers of leukaemia progenitors and increased numbers of differentiated cells ( Supplementary Fig. 19 ). Collectively, these results indicate that the binding of ANGPTLs to PIRB promotes leukaemia development, probably through inhibiting differentiation of AML cells. LILRB2 and PIRB are known to bind to other ligands, including various MHC class I molecules 28 and myelin inhibitors 17 . It will be important to investigate the in vivo context in which these different ligands bind LILRB and induce signalling. As ANGPTLs can be abundantly expressed by many types of cells, including those from endocrine organs 11 and potential bone marrow niche (endothelium and adipocytes 9, 11 ), and can be induced by hypoxia 11 , these secreted factors may have important direct and indirect effects on the activities of HSCs and leukaemia stem cells in vivo. Although the LILRB/PIRB receptors were reported to suppress activation of differentiated immune cells and inhibit neurite outgrowth of neural cells 16, 17 , they support HSC repopulation and inhibit differentiation of AML cells. This result suggests the importance of these 'inhibitory receptors' in maintenance of stemness of normal stem cells and support of leukaemia development. In contrast to the 'stimulatory receptors' such as interferon receptors or Toll-like receptors that activate and induce differentiation of HSCs upon inflammation 29 , LILRB2 and PIRB may function as sensors of inflammation through binding to the inflammatory ANGPTLs 12 and protecting HSCs from excessive activation and exhaustion. Adult stem cells and cancer cells probably require both stimulatory receptors and inhibitory receptors to maintain the balance of their cell fates.
METHODS SUMMARY
Plasmid cytomegalovirus (CMV)-Kozak human Angiopoietin-1 and ANGPTL 1, 2, 3, 4, 6 and 7 with Flag tags at the carboxy terminus were used for transfection. ANGPTL2-Flag was purified using M2 resin. Purified GST-ANGPTL5 was purchased from Abnova. Bacterially expressed Flag-ANGPTL2 (with Flag at the amino terminus) and ANGPTL2-Flag (with Flag at the C terminus) were constructed in pET-26b(1) vector, and GST-ANGPTLs-Flag in pGEX vector, and expressed and purified from bacteria. Murine stem cell virus (MSCV)-LILRB2-IRES-green fluorescent protein (GFP) or control retrovirus-infected Baf3 cells, CMV-driven LILRA-, LILRB-, PIRB-, or LAIR1-transfected 293T cells, or human mononuclear cord blood cells were used in binding assays. See the Methods for detailed experimental methods for flow cytometry, coimmunoprecipitation, SPR, liquid-phase binding, culture, transplantation, c.f.u. and gene set enrichment analysis (GSEA). Mice were maintained at the University of Texas Southwestern Medical Center animal facility. All animal experiments were performed with the approval of University of Texas Southwestern Committee on Animal Care. 
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METHODS
Mice. C57BL/6 CD45.2 and CD45.1 mice, or NOD/SCID mice, were purchased from the University of Texas Southwestern Medical Center animal breeding core facility. The PIRBTM mice 18 were obtained from the MMRRC. The PIRB knockout mice 30 were a gift from T. Takai. Mice were maintained at the University of Texas Southwestern Medical Center animal facility. All animal experiments were performed with the approval of the University of Texas Southwestern Committee on Animal Care. Plasmids and proteins. Plasmid CMV-Kozak human Ang1 and ANGPTLs 1, 2, 3, 4, 6 and 7 with Flag tags at the C terminus were transfected into 293T cells using Lipofectamine 2000, and the conditioned medium at 48 h was collected and different ANGPTL proteins were adjusted to the same level for flow cytometry-based binding experiments. ANGPTL2-Flag was purified using M2 resin. Purified GST-ANGPTL5 was purchased from Abnova. Bacterially expressed Flag-ANGPTL2 and ANGPTL2-Flag were constructed in pET-26b(1) vectors, and GST-ANGPTLs-Flag in pGEX vectors, and expressed and purified from bacteria. MSCV-LILRB2-IRES-GFP-or control retrovirus-infected Baf3 cells, or CMVdriven LILRA-, LILRB-, PIRB-or LAIR1-transfected 293T cells collected at 48 h, or mononuclear human cord blood cells were incubated with Fc block and equal amounts of different Flag-tagged ANGPTLs at 4 uC for 60 min, followed by staining with anti-Flag-allophycocyanin (APC) and propidium iodide. Anti-LILRB2phycoerythrin (PE) was used as indicated. Cells were analysed using either a FACSCalibur or FACSAria instrument (Becton, Dickinson). Antibodies and shRNAs. Flow cytometry antibodies anti-CD34-fluorescein isothiocyanate (FITC), anti-CD38-PE, anti-CD90-PE/Cy5.5, biotinylated lineage cocktail, anti-Kit-APC, anti-Sca-1-FITC, anti-Mac-1-APC, anti-Gr-1-PE, anti-CD3-APC and anti-B220-PE were purchased from BD Biosciences and used as described 4, 9, 10, 31 . The manufacturers and catalogue numbers for other antibodies are as follows: anti-LILRB1, Biolegend (33707); anti-LILRB2, eBioscience (12-5149); anti-LILRB3, eBioscience (12-5159); anti-LILRB4, eBiosciene (12-5139); anti-LILRB5, R&D Systems (AF3065); anti-PIRB-PE, R&D Systems (FAB2754P); anti-human LAIR1-PE, BD Pharmingen (550811); anti-mouse LAIR1-PE, eBioscience (12-3051); anti-Flag-APC, Prozyme (PJ255); anti-pCAMK2, Abcam (ab32678); anti-pCAMK4, Santa Cruz (sc-28443-R); anti-CAMK2, Cell Signaling (4436); anti-CAMK4, Cell Signaling (4032); anti-ANGPTL5, Abcam (ab57240); anti-PIRB, BD Pharmingen (550348) for coimmunoprecipitation of PIRB; anti-SHP-2, Cell Signaling (3397S) for coimmunoprecipitation of SHP-2; and anti-Fc, Jackson ImmunoResearch (109-036-098 Coimmunoprecipitation. For in vivo coimmunoprecipitation, 293 cells were transiently co-transfected with plasmids encoding LILRB2-ECD-Fc, PIRB-ECD-Fc, or Tie-2-ECD-Fc and Flag-tagged ANGPTL2 or untagged ANGPTL5. Protein A beads were added to conditioned medium collected at 48 h after transfection, and proteins were detected by anti-Flag or anti-ANGPTL5 by western blot. For in vitro coimmunoprecipitation, purified ANGPTL2-Flag or GST-ANGPTL5 was incubated with purified LILRB2-ECD-Fc or Tie-2-ECD-Fc in PBS with 0.1% BSA and 0.1% NP-40 for 2 h followed by immunoprecipitation with protein A beads and western blotting. Liquid-phase binding assay. Specific binding of radiolabelled GST-ANGPTL5 to Baf3 stably infected with MSCV-LILRB2-IRES-GFP (as LILRB2-Baf3 cells) was performed in a similar manner to before 32 . In brief, 6 3 10 6 LILRB2-Baf3 cells were incubated with 125 I-GST-ANGPTL5 (0.1-100 nM) in 200 ml PBS/1% BSA for 3 h at 25 uC. Nonspecific binding on normal Baf3 cells was subtracted. In competition assay, 2.5 3 10 6 LILRB2-Baf3 or Baf3 cells were incubated with unlabelled GST-ANGPTL5 (0.1-100 nM) in 200 ml PBS/1% BSA for 1 h at 25 uC, followed by addition of 5 nM of 125 I-GST-ANGPTL5 and incubation for 4 h. After incubation, the cells were washed twice by centrifugation, resuspended in ice-cold PBS with 1% BSA and then measured in a scintillation counter.
Cell culture and infection. Baf3 cells were grown in RPMI medium 1640 with 10% FBS and 10% Wehi conditioned cell medium. Human embryonic kidney 293T cells were grown in DMEM with 10% FBS. For mouse HSC culture, indicated numbers of bone marrow Lin 2 Sca-1 1 Kit 1 CD34 2 Flk-2 2 cells or fetal liver Lin 2 Sca-1 1 Kit 1 cells isolated from 8-10-weekold C57BL/6 CD45.2 mice were plated in one well of a U-bottom 96-well plate (Corning) with 200 ml of the indicated medium, essentially as we described previously 4, 9 . Cells were cultured at 37 uC in 5% CO 2 and indicated levels of O 2 . For the purpose of competitive transplantation, we pooled cells from 12 culture wells and mixed them with competitor/supportive cells before the indicated numbers of cells were transplanted into each mouse. For western blotting, 3-week-old mouse spleen cells were cultured overnight in DME supplemented with 0.1% BSA, followed by treatment with indicated amount of ANGPTLs. Human mononuclear cord blood cells were cultured in DME containing 10% FBS overnight followed by starvation in serum-free DME for 4 h before ANGPTL stimulation.
The infection of Lin 2 cells by MSCV-MLL-AF9-IRES-YFP and MSCV-AML1-ETO9a-IRES-GFP was performed after procedures described in refs 22,23 and 33, respectively. In brief, we incubated Lin 2 cells overnight in medium with 10% FBS, 20 ng ml 21 SCF, 20 ng ml 21 IL-3 and 10 ng ml 21 IL-6, followed by spin infection with retroviral supernatant in the presence of 4 mg ml 21 polybrene. Infected cells (300,000) were transplanted into lethally irradiated (1,000 rad) C57BL/6 mice by retro-orbital injection.
For human cell culture, fresh and cryopreserved human cord blood cells were obtained from University of Texas Southwestern Parkland Hospital through approved IRB protocol 042008-033. CD34 1 cells were isolated by AutoMACS and grown essentially as we described 1,10 . CD133 1 cells were purchased from AllCell. Lentiviral infection by shRNAs for LILRB2 or ANGPTLs was performed as recommended by Open Biosystems. Flow cytometry and reconstitution analysis. Donor mouse bone marrow cells were isolated from 8-10-week-old C57BL/6 CD45.2 mice. Bone marrow Lin 2 Sca-1 1 Kit 1 CD34 2 Flk-2 2 cells were isolated by staining with a biotinylated lineage cocktail (anti-CD3, anti-CD5, anti-B220, anti-Mac-1, anti-Gr-1, anti-Ter119 and anti-7-4; Stem Cell Technologies) followed by streptavidin-PE/Cy5.5, anti-Sca-1-FITC, anti-Kit-APC, anti-CD34-PE, and anti-Flk-2-PE. The indicated numbers of mouse CD45.2 donor cells were mixed with 1 3 10 5 freshly isolated CD45.1 LETTER RESEARCH
